You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2025

Bulk Pharmaceutical API Sources for POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Get Started Free 204099_ALDRICH ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free 409316_ALDRICH ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free 449989_ALDRICH ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free 451029_ALDRICH ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for: Potassium Chloride 10 mEq in Plastic Containers

Last updated: August 5, 2025

Introduction

Potassium Chloride (KCl), a vital electrolyte used in medical treatments to prevent and treat hypokalemia, is supplied globally through numerous bulk API manufacturers. For pharmaceutical companies and healthcare providers, sourcing high-quality, reliable API is paramount to ensure safe, effective, and regulatory-compliant medications. This article examines the principal sources of bulk KCl API, particularly for formulations intended for 10 mEq dosages in plastic containers, highlighting key manufacturers, sourcing considerations, regulatory compliance, and market dynamics.

Overview of Potassium Chloride as an API

Potassium Chloride (KCl) in bulk form exists primarily as a crystalline powder or solution, with pharmaceutical-grade quality meeting standards such as USP, EP, or JP monographs. The API's production involves chemical synthesis with rigorous purification to eliminate impurities, ensuring safety for parenteral and oral dosage forms. The 10 mEq dosage, common for intravenous or oral administration, necessitates that suppliers adhere to strict quality and purity parameters for bulk procurement.

Global API Suppliers for Potassium Chloride

1. Major Pharmaceutical and Chemical Manufacturers

A. Tosoh Corporation (Japan)
Tosoh is recognized for its high-purity inorganic salts, including pharmaceutical-grade KCl. Its facilities produce KCl that complies with USP and EP standards, suitable for both oral and IV formulations. Tosoh's extensive quality assurance processes make it a preferred supplier for global pharmaceutical companies seeking consistent API quality.

B. Gadot Biochemica (Israel)
Gadot Biochemica supplies pharmaceutical-grade KCl, focusing on high-purity inorganic salts. Its manufacturing facilities are GMP-certified, ensuring products meet international pharmacopoeial standards. The company offers bulk KCl in various packaging, including bulk containers suitable for large-scale pharmaceutical manufacturing.

C. Sigma-Aldrich (Part of MilliporeSigma/America)
Sigma-Aldrich supplies pharmaceutical-grade KCl as a bulk API, providing comprehensive documentation, stable supply chains, and adherence to regulatory standards, making it a popular choice for API procurement globally.

D. Fresenius Kabi (Germany)
An established leader in injectable pharmaceuticals and APIs, Fresenius produces pharmaceutical-grade KCl suitable for IV formulations. The company emphasizes rigorous quality control, complying with international pharmacopoeias and providing APIs suitable for plastic container packaging.

E. Shandong Xinhua Pharmaceutical (China)
This Chinese manufacturer supplies bulk pharmaceutical KCl globally, with a focus on cost-effective, high-quality API compliant with USP, GMP, and other standards. Their capacity for large-volume production and extensive export network make them a significant API source.

F. Yancheng Huaqiang Biological Products Co., Ltd. (China)
Specializing in inorganic salts, this company offers pharmaceutical-grade KCl with documentation suitable for regulated markets. Their production facilities are GMP-compliant, and they provide bulk API in various packaging, including containers optimal for pharmaceutical use.

2. Regional Suppliers with Growing Market Presence

  • Cosenza Pharma (Italy): Offers pharmaceutical-grade KCl suitable for hospital and pharmaceutical use, emphasizing quality standards aligned with European directives.

  • Hubei Shijiheng Pharmaceutical Co., Ltd. (China): Provides cost-competitive KCl API with GMP compliance for global distribution.

Key Sourcing Considerations

A. Quality and Regulatory Compliance

Procurement must meet pharmacopoeial standards (USP, EP, JP), with particular attention to purity, low heavy metals, and absence of toxins. Certificates of Analysis (CoA) and GMP compliance are mandatory documentation.

B. Packaging and Shipment

Bulk KCl is typically supplied in large drums, bags, or supersacks, with packaging designed to prevent moisture absorption and contamination. For formulations in plastic containers, APIs are often supplied in bulk suitable for dissolving and filling into sterile or non-sterile plastic containers.

C. Supply Chain Reliability

Given critical therapeutic uses, manufacturers look for suppliers with proven track records of consistent supply and timely delivery. Strategic partnerships often encompass supplier audits, quality control audits, and supply chain transparency.

D. Cost and Lead Times

While cost remains a key factor, quality and regulatory compliance guide procurement decisions. Lead times vary with supplier location, with Asian manufacturers typically offering more competitive pricing, whereas European and North American suppliers may provide faster shipment and higher regulatory assurance.

Regulatory and Quality Assurance

Compliance with international GMP standards is vital. Many suppliers adhere to cGMP, with certifications from regulatory agencies such as the FDA (USA), EMA (Europe), and NMPA (China). Documentation such as stability data, manufacturing process validation, and analytical methods enhance procurement confidence.

Market Dynamics and Trends

The global demand for KCl APIs is driven by increasing hospitalization rates, expanding uses in IV therapy, and ongoing shortages of high-purity inorganic salts. Chinese and Indian manufacturers are expanding capacities to meet rising demand but face scrutiny regarding quality assurance and regulatory compliance. Conversely, established Western manufacturers focus on high-purity, GMP-compliant APIs with robust documentation packages.

Packaging for 10 mEq Dosage in Plastic Containers

The API is often supplied in bulk, ready for formulation into injectable or oral preparations. Packaging is customized per client needs but frequently involves:

  • Bulk drums or bags for storage and transport.
  • Aseptic processing for injectable formulations.
  • Container compatibility considerations to prevent leaching or degradation.

Manufacturers often recommend preparing the API in a form compatible with sterile filtration or direct dissolution in water, to fill final containers—usually plastic bottles or bags—used clinically.

Conclusion

Sourcing bulk potassium chloride API for 10 mEq formulations in plastic containers requires careful evaluation of suppliers based on quality standards, regulatory compliance, supply reliability, and cost. Top global manufacturers such as Tosoh, Gadot, Sigma-Aldrich, Fresenius Kabi, and Chinese suppliers offer diverse options. Ensuring high-quality API involves validation of GMP certification, documentation, and consistent supply. As demand continues to grow, strategic supplier relationships and rigorous quality assessments will underpin successful procurement and formulation processes.


Key Takeaways

  • Prioritize GMP-compliant suppliers offering pharmaceutical-grade KCl meeting USP, EP, or JP standards.
  • Evaluate supplier certifications, especially for cGMP, stability, and analytical validation.
  • Consider geographic location, lead times, and regulatory documentation in procurement decisions.
  • Ensure packaging solutions align with formulation needs for 10 mEq dosage in plastic containers.
  • Maintain ongoing supplier audits and quality assurance processes to mitigate supply chain disruptions and ensure product integrity.

FAQs

1. What quality standards are essential for pharmaceutical-grade potassium chloride API?
Pharmaceutical-grade KCl must meet standards such as USP, EP, or JP, ensuring high purity, low impurities, and compliance with Good Manufacturing Practices (GMP). Certificates of Analysis and stability data are critical for validation.

2. Which regions are dominant suppliers of bulk potassium chloride API?
China and India are leading producers due to cost advantages and large manufacturing capacities. Europe and Japan host high-quality suppliers focusing on stringent quality standards and regulatory compliance.

3. What packaging options are typical for bulk potassium chloride API intended for plastic containers?
APIs are typically supplied in drums, supersacks, or smaller bulk containers, designed to prevent moisture ingress and contamination, suitable for downstream formulation into bottles or bags in hospital or pharmacy settings.

4. How does the choice of supplier impact regulatory approval for pharmaceutical products?
Suppliers with GMP certification, comprehensive documentation, and consistent quality records facilitate smoother regulatory approval processes, especially in stringent markets like the USA and Europe.

5. Are there any recent market trends influencing API sourcing for potassium chloride?
The increasing prevalence of IV therapy, electrolyte supplementation, and global supply chain disruptions have driven demand for reliable, high-quality API sources, prompting manufacturers to expand capacity and improve quality assurance protocols.


Sources

  1. [1] Tosoh Corporation, "Pharmaceutical Grade Potassium Chloride," Official Website, 2023.
  2. [2] Gadot Biochemica, "Inorganic Salts Production," Company Fact Sheet, 2023.
  3. [3] Sigma-Aldrich, "Potassium Chloride (API)," Product Catalog, 2023.
  4. [4] Fresenius Kabi, "API and Intermediate Supplies," Corporate Brochure, 2023.
  5. [5] MarketWatch, "Global Potassium Chloride Market Trends," 2023.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.